Cell viability experiments in MDA-MB468, MDA-MB-231, and MCF-7 (female) breast cancer cell lines gave variable responses with the Cyc analogues despite the structural similarities and biochemical activity towards DHFR (Figure 3). The gene discussed is DHFR; the disease is breast carcinoma.